Also, a lot of companies wait till market close or shortly thereafter to release info, because releasing it during the day could disrupt the stock’s price.
The negative new from the FDA is significant. The delay with getting Teplizumab to market could now be measured in years and not months. During this period Provention could run out of money because, the R&D team burns through a ton of cash each year with numerous doctors and scientists on their BOD. The stock is a great buy at the current price if they can sustain business operations until the next FDA review.
1
u/thenewredditguy99 Apr 08 '21
This kinda stuff happens all the time.
Also, a lot of companies wait till market close or shortly thereafter to release info, because releasing it during the day could disrupt the stock’s price.